glp 1 makes me nauseous Nausea & Vomiting from GLP-1 Injections Effective Solutions for GLP-1 Related

Novo Nordisk is awaiting new approvals for their oral semaglutide products

October 2023: JAMA Research Letter Warns of Possible Ozempic Risks A research letter filed in the Journal of the American Medical Association alleges the risk of adverse gastrointestinal events associated with the use of GLP-1 agonists that are used not only to treat diabetes but also off-label for weight loss

doi 10.1016/s0016-5085(24)01827-4 83 AnbazhaganANThaqiMPriyamvadaSJayawardenaDKumarAGujralTet al

No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes

Commonly Prescribed GLP-1 Medications Two of the most widely prescribed GLP-1 receptor agonists are Ozempic and Wegovy

However, it increased gastrointestinal side effects, and almost a quarter of patients experienced dysaesthesia, a painful sensation under the skin